Literature DB >> 8039973

Proliferative actinic keratosis.

L H Goldberg1, A K Joseph, J A Tschen.   

Abstract

BACKGROUND: Solar/actinic keratoses (AKS) are premalignant lesions, usually less than 1 cm in diameter, that appear on chronically sun-damaged skin.
METHODS: We describe four patients with a form of AK that enlarged and recurred despite standard treatment. Histologic examination revealed a single and multilayered sheet of anaplastic cells along the undersurface of the epidermis extending down hair follicles and present over a large area.
RESULTS: Three of the patients developed either a squamous cell carcinoma (SCC) or basal cell carcinoma (BCC) within the area encompassed by the AK.
CONCLUSIONS: These cases represent an insidious, proliferative form of AK with an increased tendency to develop into skin cancer.

Entities:  

Mesh:

Year:  1994        PMID: 8039973     DOI: 10.1111/j.1365-4362.1994.tb01065.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  Evaluation of the prognostic significance of follicular extension in actinic keratoses.

Authors:  Shaily Pandey; Stephen E Mercer; Kai Dallas; Patrick O Emanuel; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2012-04

2.  In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry.

Authors:  Alejandro Garcia-Uribe; Jun Zou; Madeleine Duvic; Jeong Hee Cho-Vega; Victor G Prieto; Lihong V Wang
Journal:  Cancer Res       Date:  2012-04-05       Impact factor: 12.701

3.  Histopathological variants of cutaneous squamous cell carcinoma: a review.

Authors:  Valerie R Yanofsky; Stephen E Mercer; Robert G Phelps
Journal:  J Skin Cancer       Date:  2010-12-29

Review 4.  Pathogenesis of Keratinocyte Carcinomas and the Therapeutic Potential of Medicinal Plants and Phytochemicals.

Authors:  Andrea Jess Josiah; Danielle Twilley; Sreejarani Kesavan Pillai; Suprakas Sinha Ray; Namrita Lall
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.